Results 31 to 40 of about 3,535 (191)

The thermogenic effect of mirabegron ingestion during cool conditions

open access: yesFrontiers in Physiology
IntroductionBrown adipose tissue (BAT) is highly thermogenic and can be stimulated by cold exposure or mirabegron, a β3-adrenergic receptor agonist. However, it is currently not known whether the thermogenic effects of mirabegron are observed during ...
Felipe Gorini Pereira   +7 more
doaj   +2 more sources

The effects of mirabegron and anticholinergic treatment on anterior segment and pupillary responses in overactive bladder syndrome [PDF]

open access: yesBMC Ophthalmology
Purpose To evaluate the effect of tolterodine and mirabegron on anterior chamber parameters and static pupillometry measurements in overactive bladder (OAB) patients and to compare these results with those of healthy controls. Methods This study included
Utku Furuncuoglu   +6 more
doaj   +2 more sources

Mirabegron attenuates porcine ureteral contractility via α1-adrenoceptor antagonism [PDF]

open access: yes, 2022
The β3-agonist mirabegron is thought to induce relaxation of the detrusor muscle, contributing to the improvement of overactive bladder symptoms. There has been recent interest in purposing mirabegron as a medical expulsive therapy drug to improve the ...
Lim, Iris   +4 more
core   +1 more source

Real-Life Data on Mirabegron in Neurogenic Bladder Dysfunction [PDF]

open access: yes, 2019
Aims: To determine factors for treatment persistence in a real-life cohort of adult neurogenic lower urinary tract dysfunction. Methods: We reviewed records of patients with neurogenic lower urinary tract dysfunction and mirabegron prescriptions ...
Lukman Hakim, Lukman   +3 more
core   +3 more sources

Investigation of the Antiremodeling Effects of Losartan, Mirabegron and Their Combination on the Development of Doxorubicin-Induced Chronic Cardiotoxicity in a Rat Model [PDF]

open access: yes, 2022
Despite the effectiveness of doxorubicin (DOXO) as a chemotherapeutic agent, dose-dependent development of chronic cardiotoxicity limits its application. The angiotensin-II receptor blocker losartan is commonly used to treat cardiac remodeling of various
Csont, Tamás   +14 more
core   +4 more sources

Mirabegron for overactive bladder [PDF]

open access: yesCanadian Family Physician
Falk, Jamie   +3 more
openaire   +3 more sources

Preliminary experience and possible predictors of successful mirabegron treatment for overactive bladder

open access: yesUrological Science, 2017
Objective: The aim of this study was to report our preliminary experience of the treatment with mirabegron and to identify the predictors of a successful treatment with mirabegron in overactive bladder (OAB) patients.
Tsai-Feng Chen   +4 more
doaj   +1 more source

Impact of mirabegron versus solifenacin on autonomic function and arterial stiffness in female overactive bladder syndrome: a randomized controlled trial

open access: yesScientific Reports, 2022
The study aims to elucidate the impact of mirabegron versus solifenacin on autonomic function and peripheral arterial conditions in women with overactive bladder syndrome (OAB).
Sheng-Mou Hsiao   +4 more
doaj   +1 more source

Mirabegron, a breakthrough in overactive bladder syndrome? [PDF]

open access: yes, 2017
Objective: Overactive bladder syndrome is a condition with high prevalence, which has a negative impact on patients\u2019 quality of life. A drug with a novel mechanism of action has been recently approved: mirabegron.
Jamart Sánchez,Lucía   +4 more
core   +5 more sources

Effect of mirabegron on overactive bladder symptoms in patients with myasthenia gravis disease [PDF]

open access: yes, 2023
Aim: Overactive bladder (OAB) is a chronic, bothersome disease that decreases the quality of life and can be treated with antimuscarinic or β(3)-adrenergic agonist drugs, such as mirabegron.
Culha, Mehmet Gokhan   +9 more
core   +1 more source

Home - About - Disclaimer - Privacy